Latest Articles

Publication Date
Robot assisted hysterectomy: A health technology assessment - Folkehelseinstituttet - FHI

Robot assisted hysterectomy: A health technology assessment Folkehelseinstituttet - FHI

Published: Oct. 23, 2024, 3:51 p.m.
Robot assisted hysterectomy: A health technology assessment - fhi.no

Robot assisted hysterectomy: A health technology assessment fhi.no

Published: Oct. 23, 2024, 3:51 p.m.
Efficacy, Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer - Medpage Today

Efficacy, Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer Medpage Today

Published: Oct. 23, 2024, 2:47 p.m.
ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer - Medpage Today

ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer Medpage Today

Published: Oct. 23, 2024, 2:47 p.m.
Women with endometriosis have higher odds of postpartum hemorrhage: Study - Medical Dialogues

Women with endometriosis have higher odds of postpartum hemorrhage: Study Medical Dialogues

Published: Oct. 23, 2024, 2:30 p.m.
New Stroke Guidelines Include Sex-Specific Risks - Inside Precision Medicine

New Stroke Guidelines Include Sex-Specific Risks Inside Precision Medicine

Published: Oct. 23, 2024, 2:27 p.m.
Cardiometabolic Index Predicts Endometriosis Risk - Endocrinology Advisor

Cardiometabolic Index Predicts Endometriosis Risk Endocrinology Advisor

Published: Oct. 23, 2024, 1:29 p.m.
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times

Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times

Published: Oct. 23, 2024, 10:06 a.m.
Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis - Nature.com

Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis Nature.com

Published: Oct. 23, 2024, 4:55 a.m.
Philadelphia Woman Prepares for Her Tenth NYC Marathon Just Months After Her Fifth Endometriosis Surgery - Endometriosis Foundation of America - The Blossom

Philadelphia Woman Prepares for Her Tenth NYC Marathon Just Months After Her Fifth Endometriosis Surgery Endometriosis Foundation of America - The Blossom

Published: Oct. 22, 2024, 8 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!